Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report)’s share price gapped down before the market opened on Thursday . The stock had previously closed at $124.00, but opened at $118.50. Pro Medicus shares last traded at $118.50, with a volume of 40 shares changing hands.
Analyst Ratings Changes
Separately, Jefferies Financial Group lowered Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $155.00.
Check Out Our Latest Research Report on Pro Medicus
Pro Medicus Trading Down 4.4%
Pro Medicus Company Profile
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Read More
- Five stocks we like better than Pro Medicus
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
- One of Trump’s Favorite Stocks Just Reported Blowout Earnings
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
